Come up with a name for your new list and we'll add to it:
Sirna Therapeutics raised a round of funding on October 30, 2006. Investors include
Merck & Co..
Sirna Therapeutics develops treatments based on RNAi technology for asthma, diabetes, hepatitis C, macular degeneration and Huntington's Disease.…